Total IgE and Der p 1 (D1) specific IgE in induced sputum (IS) in patients with allergic and non-allergic asthma

E. Curto Sánchez (Barcelona, Spain), A. Crespo Lessmann (Barcelona, Spain), E. Mateus Medina (Barcelona, Spain), L. Soto Retes (Barcelona, Spain), A. García Moral (Barcelona, Spain), M. Torrejón Lázaro (Barcelona, Spain), A. Belda Soler (Barcelona, Spain), J. Giner Donaire (Barcelona, Spain), D. Ramos Barbón (Barcelona, Spain), V. Plaza Moral (Barcelona, Spain)

Source: International Congress 2018 – Biomarkers for evaluating asthma
Session: Biomarkers for evaluating asthma
Session type: Thematic Poster
Number: 1095
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Curto Sánchez (Barcelona, Spain), A. Crespo Lessmann (Barcelona, Spain), E. Mateus Medina (Barcelona, Spain), L. Soto Retes (Barcelona, Spain), A. García Moral (Barcelona, Spain), M. Torrejón Lázaro (Barcelona, Spain), A. Belda Soler (Barcelona, Spain), J. Giner Donaire (Barcelona, Spain), D. Ramos Barbón (Barcelona, Spain), V. Plaza Moral (Barcelona, Spain). Total IgE and Der p 1 (D1) specific IgE in induced sputum (IS) in patients with allergic and non-allergic asthma. 1095

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Changes of total IgE and specific IgE antibody to dermatophagoides pteronyssinus (Dp) in cured asthmatic children
Source: Eur Respir J 2002; 20: Suppl. 38, 334s
Year: 2002

The contents of α1-acid glycoprotein (α1-AGP) and metabolites of nitric oxide (NO) in nasal lavage fluid (NLF) of patients with bronchial asthma (BA) and allergic rhinitis (AR) and house dust mites (HDM) exposure
Source: Eur Respir J 2001; 18: Suppl. 33, 43s
Year: 2001

Association between house dust mites (HDM) number in homes and of α1–acid glycoprotein (α1-AGP) level in expired air condensate (EAC) and nasal lavage fluid (NLF) of children with bronchial asthma (BA) and allergic rhinitis (AR)
Source: Eur Respir J 2005; 26: Suppl. 49, 693s
Year: 2005

Allergic asthma: total serum IgE age variations
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002

The influence of the allergen-specific immunotherapy (ASIT) against the backdrop of an immunomodulator in patients suffering from seasonal allergic rhinitis (SAR) on the level of cytokines, IgE and IgG.
Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others
Year: 2020


One year monitoring of children with bronchial asthma and other allergic diseases treated with inhaled corticosteroids vs cromoglycates with serum ECP (S-ECP), FEV1, total IgE and blood eosinophil count - the influence of different therapy
Source: Eur Respir J 2002; 20: Suppl. 38, 432s
Year: 2002

Levels of house dust mites (HDM) in homes of patients with bronchial asthma (BA) and the airway inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 281s
Year: 2001

Relationship between skin prick test, peripheral eosinophilic count, serum total & specific IgE and severity of asthma in atopic asthma
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Exhaled nitric oxide (FeNO) and serum IgE total (sIgE) are related to the type of sensitization in children with allergic rhinitis
Source: Annual Congress 2008 - Exercise-induced asthma, acute severe asthma and allergic rhinitis in children
Year: 2008

Zinc in serum and induced sputum of patients with allergic rhinitis and allergic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 353s
Year: 2004

The relationship between total IgE and specific antibody testing by Immunocap in screening allergic asthma
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020

Correlation of plasma IL-5 with sputum and blood eosinophils and ECP following a single nasal allergen challenge in non-asthmatic subjects with seasonal allergic rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 217s
Year: 2002

The value of the serum ECP (eosinophil cationic protein) level for monitoring the treatment of allergic bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 268s
Year: 2001

Effect of humanized monoclonal anti-IgE antibody, omalizumab, on allergen challenge-induced nasal response in subjects with allergic rhinitis and allergic asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 36s
Year: 2001

Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Antisense-ECE RNA inhibited dust mite-induced IL-5 release from PBMCs of patients with allergic asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 546s
Year: 2003

Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Specific serum IgE is associated with seasonal symptom load in children with allergic rhinitis
Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis
Year: 2008


Association of asthma and total IgE levels with human leucocyte antigen-DR in patients with grass allergy
Source: Eur Respir J 2002; 20: 79-85
Year: 2002